Newsletter Signup | Join Community
Stay Current With Skin Cancer Treatment Advances & Connect with Others
PD-1 Inhibitors Keytruda & Bavencio immunotherapy are changing the treatment of Merkel Cell Carcinoma
Libtayo (emiplimab) Receives FDA Approval for Advanced Cutaneous Squamous Cell Carcinoma
Dr Friedman of Columbia University—New York Presbyterian discusses advances in the treatment of skin Actinic Keratoses
Triple Immunotherapy for Rare Merkel Cell Skin Cancer Shows Promise
Odomzo® Shows Sustained Duration of Response of 26 Months in Treatment of Locally Advanced Basal Cell Carcinoma
Promising Activity of Pembrolizumab in Merkel Cell Carcinoma
Each year more than one million new cases of skin cancer are diagnosed in the United States.
Sonidegib Demonstrates Benefit in Advanced Basal Cell Skin Cancer in Phase II Trial.
Your doctor or nurse may suggest that you do a regular skin self-exam to check for skin cancer, including melanoma.
Merkel Cell FDA Approves Keytruda…